As a neuropathologist with additional subspecialty training in molecular genetic pathology, I believe in the integration of both well-established traditional diagnostic techniques and cutting-edge genomic techniques, allowing the most accurate understanding of a patient's disease possible. This allows for us to identify patients who may benefit from therapies specifically targeted to the patient's disease, maximizing therapeutic efficacy, while minimizing potential harmful side-effects. I am interested in the application of genomic techniques in the identification of novel tumor entities and the sub-classification of existing entities.